National Cancer Institute (NCI)’s Post

The Food and Drug Administration (FDA) recently granted marketing authorization for a blood test that detects inherited genetic changes that increase the risk of developing certain cancers. Learn more about the Invitae Common Hereditary Cancers Panel: https://go.nih.gov/24HtdLq

FDA Authorizes Blood Test for Hereditary Cancer Risk

FDA Authorizes Blood Test for Hereditary Cancer Risk

cancer.gov

Danielle Riley

Chronic Care Manager | LPN

9h

This is exciting!!

Like
Reply
Margrietha H. (Greet) Vink

Director | Research Development and Innovation | Smart Tech | Public Affairs | External Relations | Government - European Commission - United Nations | Gender & Diversity | Funding | Research | Education | Training

14h
Like
Reply
See more comments

To view or add a comment, sign in

Explore topics